VASH1-AS1
gene geneOn this page
Summary
VASH1-AS1 (VASH1 antisense RNA 1, HGNC:53215) is a long non-coding RNA gene on chromosome 14q24.3.
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53215 |
| Approved symbol | VASH1-AS1 |
| Name | VASH1 antisense RNA 1 |
| Location | 14q24.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000258301 |
| Entrez | 100506603 |
| RNAcentral | URS000075E224 — lncRNA, 1701 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 0
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
None — 0 exons
Expression profiles
Bgee: expression breadth ubiquitous, 210 present calls, max score 93.15.
Top tissues by expression
281 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ganglionic eminence | UBERON:0004023 | 93.15 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 91.80 | gold quality |
| apex of heart | UBERON:0002098 | 91.62 | gold quality |
| cortical plate | UBERON:0005343 | 90.86 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 90.16 | gold quality |
| adenohypophysis | UBERON:0002196 | 89.76 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 89.69 | gold quality |
| spleen | UBERON:0002106 | 89.68 | gold quality |
| cerebellar cortex | UBERON:0002129 | 89.52 | gold quality |
| right frontal lobe | UBERON:0002810 | 89.50 | gold quality |
| spinal cord | UBERON:0002240 | 88.96 | gold quality |
| body of pancreas | UBERON:0001150 | 88.89 | gold quality |
| amygdala | UBERON:0001876 | 88.89 | gold quality |
| right adrenal gland | UBERON:0001233 | 88.57 | gold quality |
| nucleus accumbens | UBERON:0001882 | 88.35 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 88.23 | gold quality |
| left adrenal gland | UBERON:0001234 | 87.97 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 87.91 | gold quality |
| putamen | UBERON:0001874 | 87.85 | gold quality |
| pituitary gland | UBERON:0000007 | 87.70 | gold quality |
| cingulate cortex | UBERON:0003027 | 87.41 | gold quality |
| right atrium auricular region | UBERON:0006631 | 87.39 | gold quality |
| caudate nucleus | UBERON:0001873 | 87.38 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 87.25 | gold quality |
| cerebellum | UBERON:0002037 | 87.09 | gold quality |
| adrenal cortex | UBERON:0001235 | 86.72 | gold quality |
| right lobe of liver | UBERON:0001114 | 86.62 | gold quality |
| right coronary artery | UBERON:0001625 | 86.38 | gold quality |
| left testis | UBERON:0004533 | 86.38 | gold quality |
| ventricular zone | UBERON:0003053 | 86.18 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.90 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Canonical reviewed UniProt: None (reviewed: )
All UniProt accessions (0):
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 0 (showing top):
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000214828 (14:76781825 G>A,C), RS1000749290 (14:76783573 T>C), RS1001359381 (14:76786446 G>C), RS1002700320 (14:76784173 T>C), RS1002855106 (14:76781326 C>G,T), RS1003036279 (14:76788016 G>A,T), RS1003088624 (14:76788405 G>A), RS1003633846 (14:76786212 G>A), RS1004368430 (14:76782721 T>G), RS1004815109 (14:76782657 C>T), RS1004952886 (14:76782967 G>A), RS1005171886 (14:76786036 A>G), RS1005451825 (14:76785615 A>G), RS1005621578 (14:76786320 G>A), RS1006459418 (14:76784018 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 0 entries
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Particulate Matter | decreases expression, decreases reaction, increases abundance, increases expression | 2 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | decreases expression, decreases reaction | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Vehicle Emissions | decreases expression, decreases reaction | 1 |
| Estradiol | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.